Page last updated: 2024-12-05

ethylxanthate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ethylxanthate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8823
CHEMBL ID3039661
SCHEMBL ID5690
MeSH IDM0046123

Synonyms (37)

Synonym
ethyl xanthate
xanthogenic acid, ethyl-
xanthate ,
ethyl xanthogenate
o-ethyl dithiocarbonate
einecs 205-780-8
xanthogenic acid
carbonic acid, dithio-, o-ethyl ester
ethylxanthogenic acid
ethylxanthate
ethylxanthic acid
carbonodithioic acid, o-ethyl ester
ethoxydithioformic acid
o-ethyl dithiocarbamate
brn 1740597
hsdb 5652
o-ethyl hydrogen dithiocarbonate
xanthic acid, ethyl-
ethoxymethanedithioic acid
b7b55m6mk1 ,
unii-b7b55m6mk1
4-03-00-00401 (beilstein handbook reference)
151-01-9
ethylxanthate [hsdb]
SCHEMBL5690
o-ethylxanthic acid
ethyl xanthic acid
o-ethyldithiocarbonic acid
ZOOODBUHSVUZEM-UHFFFAOYSA-N
dithiocarbonic acid o-ethyl ester
DTXSID3045063
o-ethyl hydrogen carbonodithioate
CHEMBL3039661
xanthogensaure
ethyl dithiocarbonate
o-ethyl s-hydrogen carbonodithioate
Q27274459

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The basic mechanism through which PEX reduces the liver toxicity of AAP is assumed to be the decrease in the amount of toxic metabolite formed."( Effect of potassium ethylxanthogenate on the acetaminophen hepatotoxicity in mice.
Dimova, S; Stoytchev, T, 1990
)
0.28
" PEX in a dose of 80 mg/kg body weight, administered subcutaneously or orally one hour before AAP, or simultaneously with it, induces prolongation of the survival of the experimental animals and increases LD50 of AAP."( Effect of potassium ethylxanthogenate on the toxicity and analgesic effect of acetaminophen.
Dimova, S; Stoytchev, T, 1989
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (34.38)18.7374
1990's12 (37.50)18.2507
2000's5 (15.63)29.6817
2010's3 (9.38)24.3611
2020's1 (3.13)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 49.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index49.80 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index74.84 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (49.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (2.94%)4.05%
Observational0 (0.00%)0.25%
Other33 (97.06%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]